A bout 0.9% of human neonates are born with congenital heart disease (CHD). CHD can arise from genetic and epigenetic abnormalities that affect the tight control of specification, proliferation, and migration of cardiac progenitors/myocytes. 1,2 During cardiogenesis, cardiac progenitors/myocytes proliferate in two waves: primitive heart tube shows highest proliferative activity at arterial and venous poles where latemigrating second heart field progenitors are recruited. 3, 4 Then, after the completion of looping, the working myocytes reinitiate mitotic activity, resulting in the ballooning of chambers at late gestational stages. 3,5 Non-ballooning regions, mainly mediastinal myocardium, 6,7 are distinct from appendage myocardium in their morphology, expression profile, 8 and ionic currents. 9
diverse cardiac subpopulation. In addition, the secondary effect by altered pump function in Nkx2-5 mutants may be another factor that complicates the interpretation of the phenotypes of mouse models mentioned above. In fact, hemodynamics by itself is known to be an independent factor that regulates cardiomyocyte growth. 25 Thus, it is still controversial whether Nkx2-5 cell-autonomously regulates cardiomyocyte growth.
The atria serve as booster pumps, volume reservoir, and neurohormonal sensor of systemic and pulmonary circulation that facilitate an effective cardiac output. 26, 27 The atria arise from a subset of the second heart field in the venous pole of heart tube, 7, [28] [29] [30] and their malfunction and malformation cause various heart diseases including ASD and arrhythmia. Although the role of Nkx2-5 in the ventricles is intensely analyzed, little is known about the atrial-specific function of Nkx2-5 during heart development. In this study, we circumvent the early lethality of germline knockouts and major hemodynamic changes associated with ventricular dysfunction in inducible knockouts by generating atrial-specific conditional knockout of Nkx2-5. Our results show that Nkx2-5 deficiency in the atria causes massive enlargement of working and conduction myocardium, leading to a lethal cardiac abnormality with ASD, hyperplastic atrial myocardium, AV conduction block, bradycardia, and transient pulmonary hypertension in the absence of major ventricular dysfunction. Genome-wide transcriptome analyses revealed that Nkx2-5 suppresses Notch activity in the atria, and genetic analyses demonstrate that Notch signaling activates the proliferation of atrial chamber myocardium at fetal stages. Together, these data suggest that Nkx2-5 regulates the proliferation of both working and conduction myocytes in the atria in coordination with Notch activity.
Methods
Atrial Nkx2-5 conditional knockout mice were generated by crossing Sln-Cre knockin mice (Sln Cre/+ ) 31 and floxed-Nkx2-5 mice (Nkx2-5 flox/flox ) 22 with C57Bl/6 background. The homozygous Nkx2-5 conditional knockout mice and controls were analyzed. The newborn littermates <24 hours after birth were used for neonatal analysis. Immunostaining was performed by using antibodies as described in the Online Data Supplement. RNA sequencing was performed by using Illumina TruSeq RNA Sample Prep Kit from 250 ng of total RNA of E18.5 mutant and control atria. Rainbow reporter, Notch intracellular domain conditional expression, and Rbpjk-flox mouse models were used for clonal analysis and Notch gain-or loss-of-function analyses. Additional details are in the Online Data Supplement.
Results

Atrial-Specific Ablation of Nkx2-5 Shows Perinatal Lethality
To investigate the role of Nkx2-5 in the atria, we generated atrial-specific Nkx2-5 conditional knockout mice using Sln-Cre line. 31 Sln is expressed partially at E10.5 and fully at E12.5 in the atrial free wall, septum, sinoatrial (SA) node, and the myocardial sleeve of systemic and pulmonary veins. No lineage labeling is detected in ventricular myocytes, endocardium, or epicardium. 31 In this study, successful ablation of Nkx2-5 was confirmed by immunostaining (Online Figure I ) and RNA-seq (Online Table I ). Sln +/+ ;Nkx2-5 flox/flox and Sln Cre/+ ;Nkx2-5 flox/+ mice (hereafter referred to as controls) showed no significant abnormality in morphological, histological, echocardiographical, and electrophysiological analyses throughout the study. Unexpectedly, the overall phenotype of atrial-specific Nkx2-5 knockouts (Sln Cre/+ ;Nkx2-5 flox/flox , hereafter referred to as conditional mutants) was more severe than that of ventricular-specific knockouts. 22 The vast majority of conditional mutants died shortly after birth at P1 or P2 ( Figure 1A) , and almost all of the dead pups were conditional mutants. The body size and weight were not significantly different between conditional mutants and controls at birth ( Figure 1B ; Online Figure IIA ). Rare survivors lived at least for 6 months with no obvious signs of congestive heart failure, although the overall growth was significantly retarded with the decrease in body weight by 30% at 3 weeks of age (Online Figure IIIA ). Both left and right atria of conditional mutants were enlarged compared with conditional heterozygotes (Figures 1C, 1D , and 2A), whereas the outflow tract and the ventricle looked normal in size and structure.
Atrial-Specific Ablation of Nkx2-5 Leads to AV Conduction Block
ECG analysis revealed that the heart rate was regular but significantly slower at rest in conditional mutants at birth ( Figure 1E and 1F ). Furthermore, conditional mutants showed significantly elongated PR interval ( Figure 1F , right panel). This PR interval is much longer than previous models of Nkx2-5 mutants. [22] [23] [24] The rare survivors also showed longer PR interval (Online Figure IIIB and IIIC), although their heart rate was not significantly slower (Online Figure IIID) .
Under stressed conditions including echo studies and dissection procedure, conditional mutants frequently developed irregular heartbeat, which raised the possibility of latent arrhythmogenicity (Online Figure IVF) . In fact, previous studies demonstrated that the global deletion of Nkx2-5 after midgestational stages led to progressive conduction block. 22, 23 Therefore, we further examined whether β-adrenergic agonist exacerbate arrhythmia. Dobutamine was injected to P1 mice intraperitoneally under ECG monitoring at various doses. Although conditional mutants showed lower heart rate at resting condition ( Figure 1E and 1F), the heart rate responded to dobutamine stimulation (Online Figure IIB) . However, the injection of dobutamine induced second-degree AV conduction block and second-degree SA block in all 4 conditional mutants tested (Online Figure IIC ): 2 were induced at a dosage of 50 ng/g and 2 at 125 ng/g of dobutamine. On the other hand, control newborns did not show arrhythmia even at a dosage of 125 ng/g intraperitoneally. Ventricular tachycardia and ventricular fibrillation were not induced in any cases. Thus, catecholamine stimulation elicited latent conduction block in atrial-specific Nkx2-5 knockout mice. 
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Normal Ventricular Function and Transient Pulmonary Hypertension in Atrial-Specific Nkx2-5 Conditional Mutants
To further analyze the cardiac function in conditional mutants, the survivors were examined by echocardiography (Online Figure IV ). Not surprisingly, left ventricular ejection fraction was normal in survivor homozygotes at 3 weeks of age (Online Figure IVA Figure IVE) , suggesting that pulmonary hypertension is unlikely to be secondary to the hemodynamic effect of ASD on pulmonary circulation. Although the precise pathophysiology is unclear, this transient primary pulmonary hypertension is often seen in human newborns small for gestational age who are known to have a higher risk of delayed perinatal decrease of pulmonary vascular resistance and persistent fetal-like pulmonary circulation. [32] [33] [34] 
Ca 2+ Transient Assay of Nkx2-5-Null Atrial Cardiomyocytes
Because Nkx2-5 deletion led to the reduction of Ca 2+ handling parameters in ventricular cardiomyocytes in a previous Tamoxifen-mediated Nkx2-5 inducible knockout study, 24 we examined Ca 2+ transient in neonatal atrial cardiomyocytes of conditional mutants at P1 using Fluo4 Calcium indicator dye. Consistent with the previous investigation, Ca 2+ releasing time and decay kinetics of neonatal atrial cardiomyocytes were extended in conditional mutants, whereas Ca 2+ amplitude was unaffected (Online Figure V) . These results suggest that Nkx2-5 is required for the regulation of Ca 2+ handling in atrial myocytes.
Atrial-Specific Nkx2-5 Knockout Neonates Show an Increased Size of Foramen Ovale and Thickened Atrial Myocardium
Although atrial septum is not usually closed in control mice at this stage, all conditional mutants showed large foramen ovale (Figure 2A , asterisk). Quantitative evaluation on serial sections of 5 whole hearts suggests that the size of foramen ovale is significantly larger compared with the controls ( Figure 2B ; Online Figure VIA ), consistent with previous global mutant studies. 24, 35 Type 2 ASD was also found in 1 out of 3 adult survivors examined (Online Figure VIB) , but in none of 6 control littermates. The atrial septum of conditional mutants was dysmorphic, and the septum primum of conditional mutants was shorter compared with controls ( Figure 2B ; Online Figure VIA ). Great veins were connected normally to heart chambers. Remarkably, the atrial wall was significantly hypertrophic in conditional mutants. In particular, the smooth walls of atrial vestibule, septum, and myocardial sleeves of pulmonary veins were markedly thicker compared with the control ( These data suggest that Nkx2-5 deletion in the atria leads to hyperplastic atrial myocardium with enlarged foramen ovale and dysmorphic atrial septum.
Enlargement of the Cardiac Conduction System in Atrial-Specific Nkx2-5 Mutants
Having identified supraventricular bradyarrhythmia in conditional mutants, we further analyzed the impact of atrial Nkx2-5 deletion on the formation of conduction system. Lineage tracing using R26-YFP reporters indicates that Sln-Cre marks atrial working muscle, SA node, and compact AV node in the atrial side of the fibrous plane, but not in the AV (His) bundle (Online Figure VII) . The deletion of Nkx2-5 in these tissues resulted in marked hyperplasia of SA and AV nodes as shown by HCN4 + (Figure 2D -2F) and AChE + stainings (Online Figure VIII) . AV (His) bundle, which is not labeled by Sln-Cre line, was not enlarged ( Figure 2D and 2F). HCN4 was not ectopically expressed in working myocardium in vestibule or appendages ( Figure 2D ; Online Figures VIII, IX, and X). Interestingly, 3 HCN4 + myocardial tracts were identified between SA and AV nodes in both controls and conditional mutants ( Figure 2E ; Online Figure IXA; Online Movies I and II). The posterior tract starts from SA node, descends the crista terminalis (or right venous valve), and reaches the AV node through the caudal wall of the right atria. The middle tract shares its origin with the posterior tract and descends the atrial septum to reach the AV node. The anterior one starts at the anterior margin of the SA node and appears to descend the atrial septum. Conditional mutants show markedly thickened HCN4 + tracts, whereas controls show only thin HCN4 + tracts in the corresponding regions. These HCN4 + internodal tracts were negative for Cx40 in both controls and conditional mutants (Online Figure X ), suggesting that they maintain slow conduction property. Unlike a previous study of Nkx2-5 hypomorphic allele, 36 the myocardial layer of pulmonary sleeves was still Cx40 + and HCN4 − in our model, suggesting that Nkx2-5 is required earlier for the phenotypic switch of pulmonary myocardium. Taken together, these findings suggest that Nkx2-5 plays a suppressive role in the formation of not only the working atrial muscle but also the conduction system.
Nkx2-5 Regulates Proliferation of Atrial Cardiomyocytes
During late fetal and neonatal stages, the cardiomyocytes undergo transition from hyperplastic to hypertrophic growth. To examine the mitotic activity of thickened myocardium and conduction cells in mutants, we performed phospho-histone H3 (PH3) staining on neonatal heart sections. Mutant hearts showed ≈2-fold increase in the number of PH3 + /cTnT + cells in both working atrial muscle and conduction system on tissue sections ( Figure 3A-3C ). Primary culture of neonatal atrial myocytes also revealed abundant PH3 + /cTnT + myocytes in culture in mutants (Online Figure XI) . As another quantitative readout, the DNA content of atrial myocytes was measured by FACS. P1 atrial tissues were dissociated and stained for cTnT and 7AAD. Histogram revealed that the percentage of cardiomyocytes in S and G2/M phase was significantly increased in conditional mutants in vivo ( Figure 3D and 3E) . These results suggest that the ablation of Nkx2-5 results in higher mitotic activity of atrial cardiomyocytes.
DNA synthesis, karyokinesis, and cytokinesis do not always correlate in muscle cells, and hypertrophic response could also result in an increase of PH3 + cells or S/G2/M cells in cardiomyocytes. To examine whether cardiomyocytes proliferate at clonal level in situ in the atria, we used Rainbow multicolor reporter mouse line, which harbors 4 fluorescent genes franked by 3 mutant Lox sequences under CAGGS promoter/enhancer targeted into R26 locus. 37 Because the recombination occurs in a stochastic manner, a single-colored cluster suggests cells from a single Sln + cell. Sections from Sln-Cre;R26-Rainbow hearts showed mainly 1-or 2-cell clusters, suggesting that atrial myocytes normally have only limited capacity of proliferation after the expression of Sln at late gestational stages ( Figure 4A-4C ). On the other hand, multicolor lineage tracing in Nkx2-5 conditional knockout background consistently showed a mild but significant shift toward multicell clusters in both atria, SA node, and AV node (Figure 4B and 4C) . Although we did not find a large (≈10 cells) cluster of cardiomyocytes in single color in either controls or mutants, our data demonstrate that the absence of Nkx2-5 leads to modest but consistent increase in the proliferative activity of atrial myocytes at late gestational-neonatal stages.
We further examined whether hyperproliferation starts during embryonic stage in conditional mutants. A significant expansion of the myocardial layer was already observed in dorsal atrial wall and septum as early as at E13.5 (Online Figure XII) , when the size of the foramen ovale and atrial chambers was still comparable between conditional mutants and controls. PH3 staining at this stage showed increased proliferative activity in both working myocardium and AV node in conditional mutants during embryonic stage (Online Figure XIII) . PH3 count was not increased in SA node at this stage (Online Figure XIIIC) , possibly because SA node does not express Nkx2-5 until late gestational stages. 38, 39 CD31 and Flk1 stainings did not show a clear increase in coronary capillaries in the hyperplastic myocardium in conditional mutants (Online Figure XIII and XIV) . Thus, hemodynamic alteration or increased vascularity is not likely the primary cause of hyperplastic atria. These data suggest that, in contrast to its pro-mitotic role during pre-looping stages, 4,12,13 Nkx2-5 plays a suppressive role on cardiomyocyte proliferation after chamber ballooning stages and confines atrial myocardium and the conduction system.
Gene Expression Profiling of Nkx2-5-Null Atria
To examine the mechanism underlying the hyperproliferation of Nkx2-5-null atrial myocytes, we performed RNA sequencing analysis using E18.5 atria between conditional homozygotes and controls (GSE52080; summarized in Online Table  I ). Known targets of Nkx2-5 including ANF and BNP, were significantly downregulated in conditional mutants (6.1-and 4.5-fold, respectively). Consistent with histological analyses, a global upregulation of cell cycle process genes was observed in conditional mutants (Table) . Genes upregulated >4-fold include Notch downstream gene Hey2 (6-fold), Wnt-related gene Sfrp5 (6-fold), and methyltransferase Smyd2 (5-fold), which are all implicated in the promotion of cardiomyocyte proliferation (Online Table I ). Hey2 is a Notch downstream gene and shows ventricular-specific expression in cardiogenesis. Previous studies suggest that Hey2-knockout mice are embryonically lethal with a thin myocardium, suggesting an essential role of Hey2 in the regulation of cardiomyocyte proliferation. 40 Smyd2 and Sfrp are implicated in cell proliferation through phosphorylation of Rb protein 41 and inhibition of Wnt signaling, 42 respectively. Bmp10 was moderately upregulated in the mutants (1.5-fold), consistent with the role of Nkx2-5 in the ventricles. 22 No evidence for genome-wide dedifferentiation or atrial-ventricular misspecification was detectable in our RNA-seq profile: β/α-MHC, Glut-4/1, or LDH-4/1 indices were not increased, nor were the markers for progenitors including Isl1 and PDGFRα, upregulated. Atrial specification genes including Nr2f2 and Tbx5 showed no significant change. Ventricular-specific markers including Irx4 and Myl2 were not elevated.
Notch Signaling Regulates the Proliferation of Atrial Myocytes
Gene ontology analysis from genes upregulated in atrial tissues of conditional Nkx2-5 mutants revealed a global activation of Notch signaling ( Figure 5A ). Known targets of Notch pathway including Hey2, Myc, Nrg1, and Bmp10 are significantly upregulated, and Notch pathway was the most significantly enriched genetic program among the major molecular signaling pathways (Online Table II ). Indeed, immunostaining with an antibody recognizing cleaved Notch2 receptor confirmed strong activation of Notch pathway in atrial myocytes ( Figure 5B ). Thus, Notch pathway is one of the key signaling cascades coordinating cardiac proliferation with Nkx2-5. Notch signaling is known to regulate proliferative activity and conduction cell formation in ventricles. [43] [44] [45] [46] To examine the role of Notch signaling in the atria, we performed genetic gain-and loss-of-function studies. Atrial-specific overexpression of Notch intracellular domain 47 resulted in remarkable hyperplasia of working myocytes with strong PH3 + staining ( Figure 6A and 6B, dotted lines) . The pattern of hyperplasia is similar to that of atrial-specific Nkx2-5 mutants in that vestibule and septum are most strongly thickened ( Figure 6A and 6B). This hyperplastic response is more likely independent of Rbpjk, because atrial-specific deletion of Rbpjk showed only a marginal decrease in the number of PH3 + atrial myocytes (Online Figure XV) . Unlike ventricular-specific activation of Notch 46 or atrial-specific deletion of Nkx2-5 in this study, gain-or loss-of-function of Notch signaling did not affect the size of SA or AV nodes ( Figure 6A and 6C; Online Figure  XV) . Thus, while Notch signaling induces the proliferation of working myocytes in the atria, the formation of atrial conduction system is differentially regulated by Notch.
Together, our data suggest that hyperproliferation of atrial myocytes and the conduction system underlies heart anomalies in Nkx2-5 mutants including ASD, atrial hyperplasia, and AV conduction block, and that Nkx2-5 and Notch signaling coordinately modulate the growth of atrial myocytes and conduction cells ( Figure 6D ).
Discussion
During late cardiogenesis, cardiomyocytes reinitiate mitotic activity at chamber ballooning stages. The analyses of the molecular mechanism of cardiac proliferation at this stage have been hampered by early lethality of conventional knockout and ventricular dysfunction in inducible mutants. In this report, we circumvented these limitations by atrial-specific deletion of Nkx2-5 and demonstrated major atrial abnormalities often observed in clinical settings including ASD and supraventricular bradyarrhythmia and blocks. Hyperplasia of working and conduction myocardium underlies these abnormalities. Hyperplastic HCN4 + myocardium enabled us to define 3 major internodal tracts that connect SA and AV nodes. Furthermore, we uncovered that Notch signaling coordinates with Nkx2-5 to regulate the growth of working and conduction myocytes in the atria. Because our models are devoid of major secondary effect of hemodynamic failure, these results suggest a primary role of Nkx2-5 in the development and function of the atria.
Previous reports using genetically modified mice showed that the disruption of Nkx2-5 in both atria and ventricles leads to congenital heart abnormalities including supraventricular bradyarrhythmia and ASD (summarized in the Online Table  III) , [22] [23] [24] 35, 48, 49 which are also identified in multiple human families affected by the heterozygous mutation of NKX2-5. [16] [17] [18] [19] AV conduction defects were common to all these mouse models and ours, although the AV conduction time is significantly longer in our atrial-specific Nkx2-5 mutants. 35, 48 Second-and third-degree AV conduction blocks were observed in mice with tamoxifen-induced global Nkx2-5 deletion and ventricular-specific deletions, 22, 23, 49 and severe block was induced in our model by dobutamine stimulation. Our atrial-specific mutants also showed a significantly lower heart rate at rest at P1 compared with heterozygous littermates. The enlarged foramen ovale and ASD are also common in previous mutants. 24, 35, 48 Although the heterozygous knockout mice showed septal dysmorphology in ≈20% of animals, 35, 48 our conditional mutants and tamoxifen-induced Nkx2-5 deletion after E12.5 showed it in even higher penetrance. 24 In contrast, ventricularspecific deletion of Nkx2-5 does not develop ASD. 22 These data suggest a cell-autonomous role of Nkx2-5 during the maturation of septal and conduction myocardium in the atrial chamber.
A major phenotypical difference between our atrial-specific deletion model and previously reported global mutants is hyperplasia of the myocardium. Whereas tamoxifen-induced Nkx2-5 deletion at similar stages showed thin atrial septum and thin ventricular wall, 24 our atrial-specific ablation showed hyperplasia of the atrial myocardium. These contrasting results raise the possibility that loss of Nkx2-5 in the ventricles may cause the complication of cardiac pump function, which secondarily affects the proliferation of atrial myocytes. 25 Our result is in line with the phenotype of previous Mlc2v-Cre deletion, which showed hypertrabeculation of the ventricles. 22 A zebrafish study also demonstrated that Nkx2-5 morphants show surplus of atrial cardiomyocytes. 50 Thus, Nkx2-5 may serve as a negative regulator of cardiomyocyte proliferation, and hyperplasia of the atrial myocardium possibly underlies the characteristic phenotypes of atrial-specific Nkx2-5 mutants.
An interesting finding is the marked enlargement of HCN4 + internodal tracts in the absence of Nkx2-5. The existence of specialized Purkinje-like fibers connecting SA and AV nodes was proposed a century ago by Thorel (posterior tract), Wenckebach (middle tract), and Bachmann (anterior and interatrial tracts). Experimental ablation of these tracts resulted in AV conduction delay. 51, 52 Although the formations of SA node, AV node, and Purkinje fibers are well analyzed, little is known about the mechanism of formation of internodal conduction cells. Our study identified HCN4 + myocardial tracts that anatomically correspond to internodal conduction tracts reported previously (Online Movie I and II), although it remains controversial whether they are the primary conduction pathways. HCN4 + domain appears to coincide with myocardium expressing Tbx3 and HNK-1. 53, 54 The expression of these genes is gradually restricted during cardiogenesis, suggesting that the atrial conduction system and internodal tracts represent developmental remnants of primitive myocardium. Nkx2-5 deficiency leads to marked hyperplasia of HCN4 + internodal tracts in our analyses, suggesting that the expression of Nkx2-5 in the myocardium is essential for the confinement of HCN4 + myocardium. This finding is consistent with the previous analysis of hypomorphic mutants demonstrating that Nkx2-5 is required for the establishment of a gene expression border between the working atrial myocardium and SA node. 39 Our data suggest that overproliferation contributes to the enlargement of conduction myocardium in the absence of Nkx2-5. However, it is possible that a fraction of hyperplastic conduction cells is transdifferentiated from working myocardium, or that non-ballooning myocardium (mainly mediastinal myocardium) remains positive for HCN4. Because SA nodal cells do not express Nkx2-5 until later fetal stages, 38, 39, 55 it is possible that Nkx2-5 confines the SA node via secreted and/or membrane-bound factors from surrounding working myocardium. This suppressive activity of Nkx2-5 on atrial conduction cells is in sharp contrast with previous observations in other models that the reduction of Nkx2-5 level causes hypoplastic AV node 21, 22 and Purkinje fibers. 56 These opposing functions of Nkx2-5 in atrial and ventricular conduction systems may point to the chamber-specific role of Nkx2-5 during cardiogenesis or may simply reflect the secondary effect of hemodynamic alteration in these models. In either case, cardiogenesis requires tight spatiotemporal control of Nkx2-5 function in diverse cardiac lineages including the working myocardium, septa, and conduction system, as well as coordinated development of the hemodynamic pattern. After 2 proliferation waves, cardiomyocytes undergo terminal differentiation and transit from hyperplastic to hypertrophic growth at birth. Our data raise the possibility that the hyperplastic phase can be enhanced or prolonged by the inhibition of Nkx2-5 and activation of Notch signaling pathway. With the advances in fetal diagnosis of CHD, strategies to control hyperplastic growth of cardiomyocytes at this stage would be of therapeutic value.
Although the majority of human CHDs are sporadic, familial CHD patients show genetic linkage with the mutation of cardiac genes including NKX2-5, GATA4, and TBX5. 16, 57 Investigations by us and others suggest that Nkx2-5 regulates the number and/ or mass of myogenic cells. 4, 22 Tbx5 is also implicated in the regulation of cardiomyocyte proliferation in vitro. 58 Human mutations in Notch and RAS/MAPK signaling, which are both critical for cardiomyocyte proliferation, also lead to syndromic congenital malformation including heart conduction block and ASD. 59 Collectively, these findings implicate that dysregulation of proliferation in the developing heart may be a key to understand the pathogenesis of common CHDs.
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